erlotinib hydrochloride has been researched along with Endotoxemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, Z; Liao, C; Ling, C; Liu, X; Liu, Y; Liu, Z; Luo, S; Tang, J; Xie, P; Xiong, Z; Zhang, L; Zhang, X | 1 |
| Gu, M; Hong, X; Liang, J; Lu, C; Sun, X; Tang, J; Wang, X; Xu, W; Yao, X; Zhong, T | 1 |
2 other study(ies) available for erlotinib hydrochloride and Endotoxemia
| Article | Year |
|---|---|
EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis.
Topics: Endotoxemia; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lipopolysaccharides; Macrophage Activation; Phosphorylation; Protein-Tyrosine Kinases; rab GTP-Binding Proteins; Sepsis; Toll-Like Receptor 4 | 2022 |
The activation of EGFR promotes myocardial tumor necrosis factor-α production and cardiac failure in endotoxemia.
Topics: Animals; Endotoxemia; ErbB Receptors; Erlotinib Hydrochloride; Heart Failure; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Quinazolines; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |